UB Paderborn / Katalog / Suche / in CDI

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1061-1069

2017

Volltextzugriff (PDF)

Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105

Journal of clinical oncology, 2020-07, Vol.38 (19), p.2122-2129

2020

Volltextzugriff (PDF)

A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2

Supportive care in cancer, 2023-12, Vol.31 (11), p.637-637, Article 637

2023

Volltextzugriff (PDF)

Improving Sexual and Gender Minority Cancer Care: Patient and Caregiver Perspectives From a Multi-Methods Pilot Study

Frontiers in oncology, 2022-05, Vol.12, p.833195-833195

2022

Volltextzugriff (PDF)

Developing a survivorship care plan (SCP) delivery process for patients and primary care providers serving poor, rural, and minority patients with cancer

Supportive care in cancer, 2021-09, Vol.29 (9), p.5021-5028

2021

Volltextzugriff (PDF)

Southwest Harvest for Health: An Adapted Mentored Vegetable Gardening Intervention for Cancer Survivors

Nutrients, 2021-07, Vol.13 (7), p.2319

2021

Volltextzugriff (PDF)

Characterizing Low-Risk Breast and Gynecological Cancer Patients for Transition into an Oncology/Primary Care Coordinated Care Model: Findings from a Survey of Diverse Survivors in a Rural U.S. State

Cancers, 2021-09, Vol.13 (17), p.4428

2021

Volltextzugriff (PDF)

The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer

Breast cancer research and treatment, 2012-04, Vol.132 (2), p.355-363

2012

Volltextzugriff (PDF)

Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature

Journal of medical case reports, 2016-12, Vol.10 (1), p.365-365, Article 365

2016

Volltextzugriff (PDF)

The Conundrum of Adjuvant HER2 Treatment Options

Frontiers in oncology, 2018-05, Vol.8, p.177-177

2018

Volltextzugriff (PDF)

Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families

Journal of genetic counseling, 2017-06, Vol.26 (3), p.480-490

2017

Volltextzugriff (PDF)

Southwest Harvest for Health: Adapting a mentored vegetable gardening intervention for cancer survivors in the southwest

Contemporary clinical trials communications, 2021-03, Vol.21, p.100741-100741, Article 100741

2021

Volltextzugriff (PDF)

Improving start-up times in oncology clinical trials: An ASCO quality improvement project

Journal of clinical oncology, 2018-10, Vol.36 (30_suppl), p.297-297

2018

Volltextzugriff (PDF)

Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update

Journal of clinical oncology, 2022-09, Vol.40 (27), p.3205-3221

2022

Volltextzugriff (PDF)

Improving the cancer survivorship journey: Developing a survivorship care transition model for rural and underserved low risk breast and gynecologic cancer patients (511)

Gynecologic oncology, 2022-08, Vol.166, p.S251-S252

2022

Volltextzugriff (PDF)

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

Journal of clinical oncology, 2021-02, Vol.39 (6), p.685-693

2021

Volltextzugriff (PDF)

Abstract P6-11-10: Patient reported measures of a breast cancer nurse navigator program in a minority, rural, and economically disadvantaged patient population

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-11-10

2020

Volltextzugriff (PDF)

Patient-Reported Measures of a Breast Cancer Nurse Navigator Program in an Underserved, Rural, and Economically Disadvantaged Patient Population

Oncology Nursing Forum, 2022-11, Vol.49 (6), p.532

2022

Volltextzugriff (PDF)

HER2-targeted therapy for early-stage breast cancer: a comprehensive review

Oncology (Williston Park, N.Y.), 2014-04, Vol.28 (4), p.281-289

2014

Volltextzugriff (PDF)

Pharmacist-driven oral oncolytic medication education and consent

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.44-44

2019

Volltextzugriff (PDF)

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update

Journal of clinical oncology, 2022-01, Vol.40 (3), p.307-309

2022

Volltextzugriff (PDF)

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update

Journal of clinical oncology, 2024-06, Vol.42 (18), p.2233

2024

Volltextzugriff (PDF)

Abstract B015: Women in survivorship health using Project ECHO: Creating a model for navigated care transitions

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_1), p.B015-B015

2020

Volltextzugriff (PDF)

Patient, provider, and nurse preferences regarding patient-reported outcomes (PRO) and side effect management during cancer treatment of minority, rural and economically disadvantaged patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18652-e18652

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105

A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2

Improving Sexual and Gender Minority Cancer Care: Patient and Caregiver Perspectives From a Multi-Methods Pilot Study

Developing a survivorship care plan (SCP) delivery process for patients and primary care providers serving poor, rural, and minority patients with cancer

Southwest Harvest for Health: An Adapted Mentored Vegetable Gardening Intervention for Cancer Survivors

Characterizing Low-Risk Breast and Gynecological Cancer Patients for Transition into an Oncology/Primary Care Coordinated Care Model: Findings from a Survey of Diverse Survivors in a Rural U.S. State

The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer

Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature

The Conundrum of Adjuvant HER2 Treatment Options

Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families

Southwest Harvest for Health: Adapting a mentored vegetable gardening intervention for cancer survivors in the southwest

Improving start-up times in oncology clinical trials: An ASCO quality improvement project

Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update

Improving the cancer survivorship journey: Developing a survivorship care transition model for rural and underserved low risk breast and gynecologic cancer patients (511)

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

Abstract P6-11-10: Patient reported measures of a breast cancer nurse navigator program in a minority, rural, and economically disadvantaged patient population

Patient-Reported Measures of a Breast Cancer Nurse Navigator Program in an Underserved, Rural, and Economically Disadvantaged Patient Population

HER2-targeted therapy for early-stage breast cancer: a comprehensive review

Pharmacist-driven oral oncolytic medication education and consent

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update

Abstract B015: Women in survivorship health using Project ECHO: Creating a model for navigated care transitions

Patient, provider, and nurse preferences regarding patient-reported outcomes (PRO) and side effect management during cancer treatment of minority, rural and economically disadvantaged patients

Endocrine and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer—Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update

Suchergebnisse filtern